Original articleDevelopment and validation of simple RP-HPLC-PDA analytical protocol for Zileuton (cas 111406-87-2) assisted with Design of Experiments for robustness determination

Add time:09/06/2019    Source:sciencedirect.com

A simple, rapid, sensitive, robust, stability-indicating RP-HPLC-PDA analytical protocol was developed and validated for the analysis of Zileuton (cas 111406-87-2) racemate in bulk and in tablet formulation. Development of method and resolution of degradation products from forced; hydrolytic (acidic, basic, neutral), oxidative, photolytic (acidic, basic, neutral, solid state) and thermal (dry heat) degradation was achieved on a LC – GC Qualisil BDS C18 column (250 mm × 4.6 mm × 5 μm) by isocratic mode at ambient temperature, employing a mobile phase methanol and (0.2%, v/v) orthophosphoric acid in ratio of (80:20, v/v) at a flow rate of 1.0 mL min−1 and detection at 260 nm. ‘Design of Experiments’ (DOE) employing ‘Central Composite Design’ (CCD) and ‘Response Surface Methodology’ (RSM) were applied as an advancement to traditional ‘One Variable at Time’ (OVAT) approach to evaluate the effects of variations in selected factors (methanol content, flow rate, concentration of orthophosphoric acid) as graphical interpretation for robustness and statistical interpretation was achieved with Multiple Linear Regression (MLR) and ANOVA. The method succeeded over the validation parameters: linearity, precision, accuracy, limit of detection and limit of quantitation, and robustness. The method was applied effectively for analysis of in-house zileuton tablets.

We also recommend Trading Suppliers and Manufacturers of Zileuton (cas 111406-87-2). Pls Click Website Link as below: cas 111406-87-2 suppliers

Prev:Original articleNovel HPTLC and UV-AUC analyses: For simple, economical, and rapid determination of Zileuton (cas 111406-87-2) racemate
Next:Revised structures for pluviatilol, methyl pluviatilol and xanthoxylol (cas 111407-29-5) : General methods for the assignment of stereochemistry to 2,6-diaryl-3,7-dioxabicyclo[3.3.0]octane lignans)